[Use of a new anti-inflammatory drug in the treatment of varicophlebitis of the lower limbs].
The paper reports the results obtained in 20 patients affected by varicophlebitis of the lower limbs following the oral administration of an anti-inflammatory substance. Results were compared with findings in single-blind study performed in a group of 20 patients treated with placebo. The evaluation of residual signs and symptoms and the control of recanalization of venous collectors using Doppler tests revealed a difference between the two groups in favour of the patients treated with the anti-inflammatory agent, although this was not statistically significant. The use of the drug was considered useful as a support to conservative varicophlebitis therapy with the aim of accelerating the resolution of the inflamed condition and thus reducing the functional disability of the limb.
Giorgetti
P L
PL
Istituto di Chirurgia Generale e Cardiovascolare dell'Università di Milano.
Bortolani
E M
EM
Morbidelli
A
A
Vandone
P L
PL
Ghilardi
G
G
Mattioli
A
A
Giordanengo
F
F
D000284:Administration, Oral; D000328:Adult; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010447:Peptide Hydrolases / Q000008:administration & dosage / Q000627:therapeutic use*; D010689:Phlebitis / Q000188:drug therapy*; D012697:Serine Endopeptidases; D014648:Varicose Veins / Q000188:drug therapy*
D000894:Anti-Inflammatory Agents, Non-Steroidal; D010447:Peptide Hydrolases; C022624:Seaprose S; D012697:Serine Endopeptidases
L'uso di un nuovo farmaco antiinfiammatorio nel trattamento delle varicoflebiti degli arti inferiori.